Replies to post #15580 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

…the real question would be why the [comparator] stocks have produced 1 year and 5 year returns of -8.8% and +144.4% on average while Momenta has returned -52% and -49% over the same time period?

Adverse litigation surely explains a lot of the disparity. What would MNTA’s valuation be now if the CAFC had not erred in Jan 2012 by wrongly invoking the Hatch-Waxman Safe Harbor in the Lovenox patent case?